Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer.

J Clin Med · 2019 · PMC6463201 · PMID 30871013

Europe PMC DOI

hedged sentence

0.1560

closest p · 3.1× alpha

0.1560

boldest claim

The sentences

did not reach statistical significancep = 0.156not close (p > 0.1)

While the prevalence of SET overexpression was higher in patients with stage III than in those cases with stage I-II disease, the differences did not reach statistical significance in this case (17.7 % vs. 11%, p = 0.156).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.